zalcitabine has been researched along with deoxyuridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Peck, A; Schinazi, RF; Sommadossi, JP | 1 |
| Chu, CK; Cretton, EM; Goudgaon, NM; Schinazi, RF; Sommadossi, JP; Xie, MY | 1 |
| Brendel, M; Cinatl, J; Doerr, HW; Gussetis, ES; Kornhuber, B; Mainke, M; Nemeth, U | 1 |
4 other study(ies) available for zalcitabine and deoxyuridine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Substrate specificity of Escherichia coli thymidine phosphorylase for pyrimidine nucleosides with anti-human immunodeficiency virus activity.
Topics: Antiviral Agents; Biological Availability; Deoxyuridine; Dideoxynucleosides; Emtricitabine; Escherichia coli; HIV; Pyrimidine Nucleosides; Stavudine; Substrate Specificity; Thymidine Phosphorylase; Zalcitabine | 1992 |
Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosides.
Topics: Animals; Antiviral Agents; Azides; Chromatography, High Pressure Liquid; Deoxyuridine; Dideoxynucleosides; Glucuronates; Hematopoietic Stem Cells; Microsomes, Liver; NADP; Oxidation-Reduction; Rats; Rats, Inbred Strains; Ribonucleosides; Uridine Diphosphate Glucuronic Acid; Zalcitabine; Zidovudine | 1992 |
2',3'-Dideoxycytidine preferentially inhibits in vitro growth of granulocyte-macrophage colony-forming cells from patients with chronic myeloid leukemia.
Topics: Bone Marrow; Deoxyadenosines; Deoxyuridine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Zalcitabine | 1991 |